Biogen
BIIB
BIIB
932 hedge funds and large institutions have $29.7B invested in Biogen in 2024 Q2 according to their latest regulatory filings, with 100 funds opening new positions, 317 increasing their positions, 335 reducing their positions, and 95 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
5% less repeat investments, than reductions
Existing positions increased: 317 | Existing positions reduced: 335
1% less funds holding
Funds holding: 943 → 932 (-11)
10% less call options, than puts
Call options by funds: $316M | Put options by funds: $353M
Holders
932
Holding in Top 10
11
Calls
$316M
Puts
$353M
Top Buyers
| 1 | +$151M | |
| 2 | +$129M | |
| 3 | +$118M | |
| 4 |
Goldman Sachs
New York
|
+$98.9M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$97.8M |
Top Sellers
| 1 | -$189M | |
| 2 | -$93.6M | |
| 3 | -$87.8M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$86.3M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$78.7M |